An Observational Study to Evaluate Impact of CRP-Level on Real World Effectiveness of Upadacitinib as Monotherapy or in Combination With MTX in Adult Participants With Rheumatoid Arthritis
Clinical trial NCT04267536 · COMPLETED
Trial details
- NCT number
- NCT04267536
- Sponsor
- AbbVie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-02-06
- Primary completion
- 2022-02-01
- Enrollment
- 534
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.